4,784 Shares in GE HealthCare Technologies Inc. $GEHC Purchased by Vise Technologies Inc.

Vise Technologies Inc. purchased a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 4,784 shares of the company’s stock, valued at approximately $354,000.

Several other hedge funds have also added to or reduced their stakes in GEHC. JPMorgan Chase & Co. increased its stake in shares of GE HealthCare Technologies by 49.9% during the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after purchasing an additional 1,711,963 shares during the last quarter. Nuveen LLC purchased a new position in shares of GE HealthCare Technologies during the 1st quarter valued at $77,058,000. Eminence Capital LP grew its stake in shares of GE HealthCare Technologies by 38.7% during the 1st quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock worth $146,822,000 after acquiring an additional 507,101 shares during the period. Homestead Advisers Corp increased its holdings in GE HealthCare Technologies by 92.7% in the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock worth $79,790,000 after acquiring an additional 475,500 shares during the last quarter. Finally, Canada Pension Plan Investment Board raised its stake in GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after acquiring an additional 409,636 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $73.15 on Monday. The stock has a market cap of $33.32 billion, a price-to-earnings ratio of 15.11, a PEG ratio of 2.75 and a beta of 1.13. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The business has a 50-day simple moving average of $75.15 and a 200 day simple moving average of $73.75. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. During the same quarter last year, the company posted $1.14 EPS. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 14th. Shareholders of record on Friday, October 24th were paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend was Friday, October 24th. GE HealthCare Technologies’s payout ratio is currently 2.89%.

Analyst Ratings Changes

GEHC has been the subject of several recent research reports. Wells Fargo & Company reduced their target price on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research note on Thursday, October 30th. Barclays assumed coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 target price on the stock. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $93.00 to $83.00 in a report on Tuesday, October 7th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Finally, Morgan Stanley increased their price target on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a report on Thursday, October 30th. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $86.10.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.